Almonty's Korean Tungsten Plant Springs to Life as a 28-Fold Rally Faces Its Toughest Exam

Almonty produces first saleable tungsten at Sangdong, posts 498% revenue surge, and launches $300M buyback amid valuation debate.

The transition from developer to producer rarely comes without friction. For Almonty Industries, that moment has now arrived at Sangdong in South Korea, where the processing facility is churning out saleable tungsten concentrate for the first time. The milestone lands at a delicate juncture: the stock has roughly 28-folded over three years, and the valuation debate is getting louder by the session.

First Concentrate, Deliberately Low-Grade

The Sangdong plant is initially drawing on a stockpile of roughly 139,700 tonnes of raw material averaging 0.25 percent tungsten trioxide. A portion of that inventory, sourced from the second quarter of 2026, carries a richer grade of 0.35 percent. Management has made a conscious call to feed lower-grade ore through the circuit first, ironing out operational kinks before transitioning to the higher-grade material that gives Sangdong its strategic cachet.

That strategy matters because Sangdong ranks among the largest high-grade tungsten deposits outside China. With Western governments and defence contractors scrambling to secure critical mineral supply chains, the project's geopolitical relevance is hard to overstate.

A Balance Sheet That Commands Attention

The corporate picture has shifted dramatically in recent months. Second-quarter revenue hit 42.99 million US dollars, while net income reached 181.8 million US dollars, buoyed by non-cash items and gains on securities. The top line tells an even starker story in Canadian dollar terms: revenue surged 498 percent year-on-year to 43.0 million, up from 7.2 million in the prior-year quarter and 69 percent ahead of the first quarter's 25.4 million.

That explosion traces back to tungsten pricing. The average European APT price climbed from roughly 453 US dollars per MTU to about 3,075 US dollars. Crucially, though, the quarter's revenue still came predominantly from the Panasqueira mine — Sangdong was only in commissioning and ramp-up mode through the period, meaning its earnings contribution has yet to appear in the numbers.

The balance sheet, meanwhile, has become a fortress. Cash and short-term investments stood at approximately 1.23 billion US dollars as of June 30, 2026, bolstered by an 800 million US dollar convertible bond issue. Operating cash flow swung to positive territory at 31.6 million Canadian dollars in the first half, reversing a 14.9 million outflow in the same period last year. The current ratio sits at a healthy 2.5.

The Buyback and the ASX Exit

Management has also secured approval to delist from the Australian Securities Exchange, concentrating trading liquidity on the Toronto Stock Exchange and Nasdaq while trimming administrative overhead. That move coincides with a 300 million US dollar share buyback programme commencing August 24, 2026, running for 36 months. The company is authorised to repurchase up to 14.4 million shares, roughly 5 percent of those outstanding.

The rationale is straightforward: the board sees a gap between the share price and the underlying value of the tungsten assets. It is a confidence signal aimed squarely at the market.

Where the Multiple Gets Complicated

That confidence is being tested against a demanding valuation. With earnings back in positive territory, the price-to-earnings ratio has become a meaningful yardstick — and it makes for uncomfortable reading. Almonty trades at a P/E of roughly 60.9, more than double the metals and mining sector average of 21.6 and well above the 30.2 mean for comparable peers. Growth-adjusted models incorporating margins, scale and risk point to a fair P/E nearer 36.4.

Independent screening by Simply Wall St tells a similar story: the company passes only half of the tests applied, with the P/E flagged as expensive both against its fair value estimate and its competitive set.

The Molybdenum Angle and What Comes Next

Beyond tungsten, Almonty is advancing a sizeable drilling programme at the adjacent Sangdong molybdenum project, aiming to confirm resources for future development. The company is positioning itself as a multi-commodity critical minerals supplier.

The real test, though, is execution. The market has already priced in a great deal of optimism. Whether the premium holds depends on Sangdong delivering the production volumes and cash flows that justify the multiple. If the ramp-up stumbles, the path of least resistance leads back toward peer-level valuations. If it succeeds, the 28-fold rally may still have room to run — but the margin for error has rarely been thinner.